Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems. - Wikidata - awgldk - TriplyDB

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

http://www.wikidata.org/entity/Q30374733

about

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin Gene transduction in mammalian cells using Bombyx mori nucleopolyhedrovirus assisted by glycoprotein 64 of Autographa californica multiple nucleopolyhedrovirus Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Universal label-free in-process quantification of influenza virus-like particles.Identification of HIV-1-Based Virus-like Particles by Multifrequency Atomic Force Microscopy.Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles.Characterization of Alternative Promoters to Stagger and Control Protein Expression in the Baculovirus-Insect Cell System: From Intracellular Reporter Proteins to Fluorescent Influenza Virus-like Particles.

P2860

Q30380290-42A3B594-B8D5-448B-BF8A-9F647254DBB9 Q37208855-6959BCB3-AFD5-488D-966A-1C5D1A68BD57 Q38886698-F92E94D3-2851-4954-8AF3-7A9ED6AE55C7 Q40198334-1353BE97-A611-47AB-B1A3-8357E189EDFF Q40571825-2F064653-DED1-4017-A34E-D4D2469A4FFE Q40572048-E3050A88-426D-44FD-B9E1-110F10B85CD3 Q46027294-62B00DFC-70DD-4B15-ADB6-6434A973AB9E

P2860

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

http://www.wikidata.org/entity/Q30374733

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@ast

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@en

type

label

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@ast

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@en

prefLabel

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@ast

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@en

P1433

Q30374733-A7AF1D49-0180-4C9E-8E19-0C74A20D1699

P1476

Q30374733-E13DC66B-5333-401D-BC7A-52D218D4F97C

P2093

Q30374733-1B8CE320-26F8-4499-BD27-8274DB040BA0

Q30374733-2394769F-3149-4611-8A63-F67C05D354B2

Q30374733-3D6A1737-6588-4B38-8AB0-E283A3FF1B64

Q30374733-5154409D-8B78-4F99-AAAE-AA5B34899399

P2860

Q30374733-0AC0799B-FB69-4A44-B926-E525EFFAC646

Q30374733-0C69B8C7-94F3-46D8-A59D-B2C2E0F6C0E1

Q30374733-0D31086E-A3C5-452E-81B3-1A4B16CEEF92

Q30374733-1C036F15-F40D-4A31-BB3B-ECE8432CEB32

Q30374733-1E0B5DEA-B30C-4EF3-A646-69A1F86EED5B

Q30374733-1ED4C5C6-C8D9-4DE1-9EE5-E8B5E3933C45

Q30374733-274F2B4F-8291-42DC-9ED2-5EFFF9907109

Q30374733-2FB77C0F-3FB5-4576-848E-9CE3297E261E

Q30374733-36250638-DD92-4477-AC81-C7A103655222

Q30374733-367B9D28-FBF1-4396-AA76-B11971DF92DA

P2888

Q30374733-90756A36-5792-4E3F-9F9E-F4A8DE1CC85E

P304

Q30374733-0A3E2729-9C27-4EA5-97C9-2C0E98EAFDDD

P31

Q30374733-41FF15FE-CC78-4D93-A7C8-B4A12B877005

P356

Q30374733-A807BAAA-CE43-4B06-8E0D-F829CDE5D515

P478

Q30374733-EE51198F-1E90-47E5-BFD1-06F717D4EDC5

P50

Q30374733-1EF2780B-6611-46D9-BCD5-EB2CD2D32A6D

Q30374733-676091E5-CA99-4923-B403-9F7EEBD840A4

P577

Q30374733-34EFBB78-00E3-4897-B971-3EF146840FCF

P5875

Q30374733-1F0DEEA2-DB7D-4C40-908F-ED7041D19444

P6179

Q30374733-53D88B94-B6A4-45D4-9D50-BEB5FF93F6E6

P698

Q30374733-1860D130-EB16-4B0D-BBF8-5D4059F0B72C

P932

Q30374733-3A510079-5938-41AA-95E2-4BC06B11C0E7

P356

S12896-015-0152-X

P1433

BMC Biotechnology

P1476

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

@en

P2093

Alaka Mullick

http://www.w3.org/2001/XMLSchema#string

Amine A Kamen

http://www.w3.org/2001/XMLSchema#string

Christine M Thompson

http://www.w3.org/2001/XMLSchema#string

Olivier Henry

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza

Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells

Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

P2888

s12896-015-0152-x

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12896-015-0152-X

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276375944

http://www.w3.org/2001/XMLSchema#string

P6179

1029670026

http://www.w3.org/2001/XMLSchema#string

P698

25981500

http://www.w3.org/2001/XMLSchema#string

P932

4432999

http://www.w3.org/2001/XMLSchema#string